Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging
DOI: 10.1055/s-0044-1785210
Review Article

COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly

Ishan Kumar 
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Mohammad Sharoon Ansari
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Ashish Verma 
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Pramod Kumar Singh
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Sankha Shubhra Chakrabarti
2   Department of Geriatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Ram Chandra Shukla 
1   Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

The World Health Organization has declared “with great hope” an end to COVID-19 as a public health emergency. The vaccination drive that started in December 2020 played a crucial role in controlling the pandemic. However, the pace at which COVID-19 vaccines were developed and deployed for general population use led to vaccine hesitancy, largely owing to concerns regarding the safety and efficacy of the vaccines. Radiology has been instrumental in demonstrating the extent of pulmonary involvement and identification of the complications of COVID-19, and the same holds true for vaccine-related complications. This review summarizes the existing body of radiological literature regarding the efficacy, adverse events, and imaging pitfalls that accompany the global rollout of various COVID-19 vaccines.

Keyword

COVID-19 vaccines - radiology - complications - effectiveness


Publication History

Article published online:
21 April 2024

© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015; 33 (34) 4161-4164
    CrossrefPubMedGoogle Scholar
  • 2 Thanh Le T, Andreadakis Z, Kumar A. et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020; 19 (05) 305-306
    CrossrefPubMedGoogle Scholar
  • 3 Wibawa T. COVID-19 vaccine research and development: ethical issues. Trop Med Int Health 2021; 26 (01) 14-19
    CrossrefPubMedGoogle Scholar
  • 4 Kumar I, Verma A, Dangwal J, Singh PK, Chandra Shukla R, Chakravarty J. Magnetic resonance imaging spectrum of COVID-associated rhino-orbital-cerebral mucormycosis and assessment of anatomical severity. Neuroradiol J 2023; 36 (04) 404-413
    CrossrefPubMedGoogle Scholar
  • 5 Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med (Torino) 2020; 125 (05) 509-513
    CrossrefPubMedGoogle Scholar
  • 6 Li K, Fang Y, Li W. et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020; 30 (08) 4407-4416
    CrossrefPubMedGoogle Scholar
  • 7 Yang R, Li X, Liu H. et al. Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging 2020; 2 (02) e200047
    CrossrefPubMedGoogle Scholar
  • 8 Verma A, Kumar I, Singh PK. et al. Initial comparative analysis of pulmonary involvement on HRCT between vaccinated and non-vaccinated subjects of COVID-19. Eur Radiol 2022; 32 (06) 4275-4283
    CrossrefPubMedGoogle Scholar
  • 9 Lee JE, Hwang M, Kim YH. et al. Imaging and clinical features of COVID-19 breakthrough infections: a multicenter study. Radiology 2022; 303 (03) 682-692
    CrossrefPubMedGoogle Scholar
  • 10 Vicini S, Bellini D, Iannarelli A. et al. Pneumonia frequency and severity in patients with symptomatic COVID-19: impact of mRNA and adenovirus vector vaccines. AJR Am J Roentgenol 2022; 219 (05) 752-761
    CrossrefPubMedGoogle Scholar
  • 11 Hanafi M, Maryetty IP. , Widiastuti Chest imaging of COVID-19 patients amongst diverse vaccination status: a comparative study using Brixia score. GSC Advanced Research and Reviews 2022; 11 (02) 045-049
    CrossrefGoogle Scholar
  • 12 Borghesi A, Zigliani A, Masciullo R. et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Med (Torino) 2020; 125 (05) 461-464
    CrossrefPubMedGoogle Scholar
  • 13 Rahman MT, Islam MI, Nahar NU, Ibrahim M, Zubery H, Shirin M. HRCT evaluation of post vaccinated RT-PCR positive COVID-19 patients at a dedicated COVID-19 hospital. European Journal of Clinical Medicine 2022; 3 (03) 14-17
    CrossrefGoogle Scholar
  • 14 Lakhia RT, Trivedi JR. The CT scan lung severity score and vaccination status in COVID-19 patients during the second wave in India: perspective of an independent radiology practice. medRxiv 2021.07.15.21260597
    Google Scholar
  • 15 Granata V, Fusco R, Villanacci A. et al. Imaging Severity COVID-19 assessment in vaccinated and unvaccinated patients: comparison of the different variants in a high volume Italian Reference Center. J Pers Med 2022; 12 (06) 955
    CrossrefPubMedGoogle Scholar
  • 16 Gurumurthy B, Das SK, Shetty S, Veerabhadrappa RC, Kosinepalli SS, Dharamaraju SH. CT severity score: an imaging biomarker to estimate the severity of COVID-19 pneumonia in vaccinated and non-vaccinated population. Egypt J Radiol Nucl Med 2022; 53 (01) 88
    CrossrefGoogle Scholar
  • 17 Dubey R, Sen KK, Mitra A, Sethi HS, Arora R, Goyal M. Correlation of radiological findings on high-resolution computed tomography chest in vaccinated and unvaccinated COVID-19 patients from Eastern India. Indian J Respir Care 2022; 11: 124-127
    CrossrefGoogle Scholar
  • 18 Su JR, McNeil MM, Welsh KJ. et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine 2021; 39 (05) 839-845
    CrossrefPubMedGoogle Scholar
  • 19 Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021; 144 (06) 471-484
    CrossrefPubMedGoogle Scholar
  • 20 Gargano JW, Wallace M, Hadler SC. et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices: United States, June 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (27) 977-982
    CrossrefPubMedGoogle Scholar
  • 21 Friedrich MG, Sechtem U, Schulz-Menger J. et al; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53 (17) 1475-1487
    CrossrefPubMedGoogle Scholar
  • 22 Fronza M, Thavendiranathan P, Chan V. et al. Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis. Radiology 2022; 304 (03) 553-562
    CrossrefPubMedGoogle Scholar
  • 23 Singh R, Chakrabarti SS, Gambhir IS. et al. Acute cardiac events after ChAdOx1 nCoV-19 corona virus vaccine: report of three cases. Am J Ther 2022; 29 (05) e579-e585
    CrossrefPubMedGoogle Scholar
  • 24 Patel YR, Shah NR, Lombardi K. et al. Cardiac MRI findings in male patients with acute myocarditis in the presence or absence of COVID-19 vaccination. Radiol Cardiothorac Imaging 2022; 4 (03) e220008
    CrossrefPubMedGoogle Scholar
  • 25 Sanchez Tijmes F, Zamorano A, Thavendiranathan P, Hanneman K. Imaging of myocarditis following mRNA COVID-19 booster vaccination. Radiol Cardiothorac Imaging 2022; 4 (02) e220019
    CrossrefPubMedGoogle Scholar
  • 26 Dionne A, Sperotto F, Chamberlain S. et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol 2021; 6 (12) 1446-1450
    CrossrefPubMedGoogle Scholar
  • 27 Sung JG, Sobieszczyk PS, Bhatt DL. Acute myocardial infarction within 24.  hours after COVID-19 vaccination. Am J Cardiol 2021; 156: 129-131
    CrossrefPubMedGoogle Scholar
  • 28 Tajstra M, Jaroszewicz J, Gąsior M. Acute coronary tree thrombosis after vaccination for COVID-19. JACC Cardiovasc Interv 2021; 14 (09) e103-e104
    CrossrefPubMedGoogle Scholar
  • 29 Özdemir İH, Özlek B, Özen MB, Gündüz R, Bayturan Ö. Type 1 Kounis syndrome induced by inactivated SARS-COV-2 Vaccine. J Emerg Med 2021; 61 (04) e71-e76
    CrossrefPubMedGoogle Scholar
  • 30 Showkathali R, Yalamanchi R, Narra L. et al. Coronary thrombo-embolic events after Covid-19 vaccination: a single centre study. Indian Heart J 2022; 74 (02) 131-134
    CrossrefPubMedGoogle Scholar
  • 31 Ifeanyi N, Chinenye N, Oladiran O, David E, Mmonu C, Ogbonna-Nwosu C. Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. J Community Hosp Intern Med Perspect 2021; 11 (06) 877-879
    CrossrefPubMedGoogle Scholar
  • 32 Al-Maqbali JS, Al Rasbi S, Kashoub MS. et al. A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. Am J Case Rep 2021; 22: e932946
    PubMedGoogle Scholar
  • 33 Wiest NE, Johns GS, Edwards E. A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines (Basel) 2021; 9 (08) 903
    CrossrefPubMedGoogle Scholar
  • 34 Borisoff BD, Bohn KD, Sager J, Gracious BL. Unprovoked submassive saddle pulmonary embolism in an adult male after Pfizer COVID-19 vaccination. Cureus 2022; 14 (08) e27717
    PubMedGoogle Scholar
  • 35 Ogunkoya JO, Ogunmola MI, Ogunlade AF, Ladele AE. COVID-19 vaccination associated bilateral pulmonary embolism: cause or coincidence. Case Rep Pulmonol 2022; 2022: 9596285
    PubMedGoogle Scholar
  • 36 Warkentin TE, Cuker A. COVID-19: Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). Waltham, MA: UpToDate; 2021
    Google Scholar
  • 37 Herrera-Comoglio R, Lane S. Vaccine-induced immune thrombocytopenia and thrombosis after the Sputnik V vaccine. N Engl J Med 2022; 387 (15) 1431-1432
    CrossrefPubMedGoogle Scholar
  • 38 Rogers P, Walker I, Yeung J. et al; RADIANT Group. Thrombus distribution in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. Radiology 2022; 305 (03) 590-596
    CrossrefPubMedGoogle Scholar
  • 39 Vierstraete M, Sabbe T. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT). Acta Chir Belg 2023; 123 (03) 329-332
    CrossrefPubMedGoogle Scholar
  • 40 Gilio M, De Stefano G. Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine. Intern Emerg Med 2022; 17 (04) 1239-1241
    CrossrefPubMedGoogle Scholar
  • 41 Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 2022; 43 (01) 3-40
    CrossrefPubMedGoogle Scholar
  • 42 Sriwastava S, Shrestha AK, Khalid SH, Colantonio MA, Nwafor D, Srivastava S. Spectrum of neuroimaging findings in post-COVID-19 vaccination: a case series and review of literature. Neurol Int 2021; 13 (04) 622-639
    CrossrefPubMedGoogle Scholar
  • 43 Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus 2021; 13 (02) e13426
    PubMedGoogle Scholar
  • 44 Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep 2021; 14 (04) e242956
    CrossrefPubMedGoogle Scholar
  • 45 Azam S, Khalil A, Taha A. Guillain-Barré syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). Am J Med Case Rep 2021; 9: 424-427
    CrossrefGoogle Scholar
  • 46 Maramattom BV, Krishnan P, Paul R. et al. Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine. Ann Neurol 2021; 90 (02) 312-314
    CrossrefPubMedGoogle Scholar
  • 47 Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barré syndrome presenting as facial diplegia after COVID-19 vaccination: a case report. J Emerg Med 2021; 61 (06) e141-e145
    CrossrefPubMedGoogle Scholar
  • 48 Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. A novel case of bifacial diplegia variant of Guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurol Int 2021; 13 (03) 404-409
    CrossrefPubMedGoogle Scholar
  • 49 Bonifacio GB, Patel D, Cook S. et al. Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry 2022; 93 (03) 341-342
    CrossrefPubMedGoogle Scholar
  • 50 Keir G, Maria NI, Kirsch CFE. Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Top Magn Reson Imaging 2021; 30 (03) 133-137
    CrossrefPubMedGoogle Scholar
  • 51 Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage-Turner syndrome following COVID-19 vaccination: MR neurography. Radiol 2022; 302 (01) 84-87
    CrossrefPubMedGoogle Scholar
  • 52 Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve 2021; 64 (01) E3-E4
    CrossrefPubMedGoogle Scholar
  • 53 Chua MMJ, Hayes MT, Cosgrove R. Parsonage-Turner syndrome following COVID-19 vaccination and review of the literature. Surg Neurol Int 2022; 13: 152
    CrossrefPubMedGoogle Scholar
  • 54 Sharma R, Dua B, Goyal S, Tiwari T. Parsonage–Turner syndrome following COVID-19 vaccine. Ann Indian Acad Neurol 2022; 25 (05) 973-975
    CrossrefPubMedGoogle Scholar
  • 55 Ghanta RB, Karistinos A, Atassi OH. Parsonage-Turner Syndrome After COVID-19 vaccination: a case report. JBJS Case Connect 2022;12(02):
    Google Scholar
  • 56 Castelli GP, Pognani C, Sozzi C, Franchini M, Vivona L. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Crit Care 2021; 25 (01) 137
    CrossrefPubMedGoogle Scholar
  • 57 Mehta PR, Apap Mangion S, Benger M. et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: a report of two UK cases. Brain Behav Immun 2021; 95: 514-517
    CrossrefPubMedGoogle Scholar
  • 58 Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet 2021; 397 (10285): e11
    CrossrefPubMedGoogle Scholar
  • 59 Kakovan M, Ghorbani Shirkouhi S, Zarei M, Andalib S. Stroke associated with COVID-19 vaccines. J Stroke Cerebrovasc Dis 2022; 31 (06) 106440
    CrossrefPubMedGoogle Scholar
  • 60 Kolahchi Z, Khanmirzaei M, Mowla A. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review. J Neurol Sci 2022; 439: 120327
    CrossrefPubMedGoogle Scholar
  • 61 Vogrig A, Janes F, Gigli GL. et al. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 2021; 208: 106839
    CrossrefPubMedGoogle Scholar
  • 62 Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg 2022; 122 (03) 793-795
    CrossrefPubMedGoogle Scholar
  • 63 Ozgen Kenangil G, Ari BC, Guler C, Demir MK. Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg 2021; 121 (04) 1089-1091
    CrossrefPubMedGoogle Scholar
  • 64 Tahir N, Koorapati G, Prasad S. et al. SARS-CoV-2 vaccination-induced transverse myelitis. Cureus 2021; 13 (07) e16624
    PubMedGoogle Scholar
  • 65 Pagenkopf C, Südmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 2021; 358: 577606
    CrossrefPubMedGoogle Scholar
  • 66 Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, Kümpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 2022; 269 (01) 55-58
    CrossrefPubMedGoogle Scholar
  • 67 Chakrabarti SS, Tiwari A, Jaiswal S. et al. rapidly progressive dementia with asymmetric rigidity following ChAdOx1 nCoV-19 vaccination. Aging Dis 2022; 13 (03) 633-636
    CrossrefPubMedGoogle Scholar
  • 68 Walter A, Kraemer M. A neurologist's rhombencephalitis after comirnaty vaccination. A change of perspective. Neurol Res Pract 2021; 3 (01) 56
    CrossrefPubMedGoogle Scholar
  • 69 DeDent AM, Farrand E. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax 2022; 77 (01) 9-10
    CrossrefPubMedGoogle Scholar
  • 70 So C, Izumi S, Ishida A. et al. COVID-19 mRNA vaccine-related interstitial lung disease: two case reports and literature review. Respirol Case Rep 2022; 10 (04) e0938
    CrossrefPubMedGoogle Scholar
  • 71 Bando T, Takei R, Mutoh Y. et al. Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination. Eur Respir J 2022; 59 (03) 2102806
    CrossrefPubMedGoogle Scholar
  • 72 Graça LL, Amaral MJ, Serôdio M, Costa B. Extensive thrombosis after COVID-19 vaccine: cause or coincidence?. BMJ Case Rep 2021; 14 (08) e244878
    CrossrefPubMedGoogle Scholar
  • 73 Leclerc S, Royal V, Lamarche C, Laurin L-P. Minimal change dis- ease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. Am J Kidney Dis 2021; 78 (04) 607-610
    CrossrefPubMedGoogle Scholar
  • 74 Lodato F, Larocca A, D'Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol 2021; 75 (05) 1254-1256
    CrossrefPubMedGoogle Scholar
  • 75 Walter T, Connor S, Stedman C, Doogue M. A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine. Br J Clin Pharmacol 2022; 88 (03) 1385-1386
    CrossrefPubMedGoogle Scholar
  • 76 Parkash O, Sharko A, Farooqi A, Ying GW, Sura P. Acute pancreatitis: a possible side effect of COVID-19 vaccine. Cureus 2021; 13 (04) e14741
    PubMedGoogle Scholar
  • 77 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (02) 239-245
    CrossrefPubMedGoogle Scholar
  • 78 Sharma A, Parekh SG. Musculoskeletal sequelae following COVID-19 mRNA vaccination. J Orthop Res 2022; 1 (03) 100044
    Google Scholar
  • 79 Wiesel BB, Keeling LE. Shoulder injury related to vaccine administration. J Am Acad Orthop Surg 2021; 29 (17) 732-739
    CrossrefPubMedGoogle Scholar
  • 80 Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM 2021; 114 (06) 424-425
    CrossrefPubMedGoogle Scholar
  • 81 Dawoud R, Haddad D, Shah V. et al. COVID-19 vaccine-related arthritis: a descriptive study of case reports on a rare complication. Cureus 2022; 14 (07) e26702
    PubMedGoogle Scholar
  • 82 Zhao Y, Wu X. Influence of COVID-19 vaccines on endocrine system. Endocrine 2022; 78 (02) 241-246
    CrossrefPubMedGoogle Scholar
  • 83 Bennet WM, Elamin A, Newell-Price JD. Subacute thyroiditis following COVID-19 vaccination: case report and Society for Endocrinology survey. Clin Endocrinol (Oxf) 2023; 98 (03) 452-453
    CrossrefPubMedGoogle Scholar
  • 84 Triantafyllidis KK, Giannos P, Stathi D, Kechagias KS. Graves' disease following vaccination against SARS-CoV-2: a systematic review of the reported cases. Front Endocrinol (Lausanne) 2022; 13: 938001
    CrossrefPubMedGoogle Scholar
  • 85 Siolos A, Gartzonika K, Tigas S. Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature. Metab Open 2021; 12: 100136
    CrossrefPubMedGoogle Scholar
  • 86 Murvelashvili N, Tessnow A. A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Investig Med High Impact Case Rep 2021; 9: 23 247096211043386
    Google Scholar
  • 87 Graf A, Armeni E, Dickinson L. et al. Adrenal haemorrhage and infarction in the setting of vaccine-induced immune thrombocytopenia and thrombosis after SARS-CoV-2 (Oxford–AstraZeneca) vaccination. Endocrinol Diabetes Metab Case Rep 2022
    PubMedGoogle Scholar
  • 88 Taylor P, Allen L, Shrikrishnapalasuriyar N, Stechman M, Rees A. Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clin Endocrinol (Oxf) 2022; 97 (01) 26-27
    CrossrefPubMedGoogle Scholar
  • 89 Varona JF, García-Isidro M, Moeinvaziri M, Ramos-López M, Fernández-Domínguez M. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Eur J Intern Med 2021; 91: 90-92
    CrossrefPubMedGoogle Scholar
  • 90 Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021; 48 (06) 1854-1863
    CrossrefPubMedGoogle Scholar
  • 91 Minamimoto R, Kiyomatsu T. Effects of COVID-19 vaccination on FDG-PET/CT imaging: a literature review. Glob Health Med 2021; 3 (03) 129-133
    CrossrefPubMedGoogle Scholar
  • 92 Demmert TT, Maric I, Pomykala KL. et al. Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls. J Nucl Med 2023; 64 (03) 368-371
    CrossrefPubMedGoogle Scholar
  • 93 Kim E, Reig B. Breast inflammatory change is transient following COVID-19 vaccination. Radiology 2022; 304 (03) 533
    CrossrefPubMedGoogle Scholar